Hepatic Abscesses: Magnetic Resonance Imaging Findings Using Gadolinium-BOPTA

Investigative Radiology

Volumn 31, Issue 12, 1996, Pages 781-788

  Runge, Val M ^a,b   Wells, John W ^a   Williams, Neil M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Contrast enhancement; Gadolinium; Liver, abscess; Liver, magnetic resonance; Magnetic resonance

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOBENIC ACID; GADOTERIDOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; IMAGE ANALYSIS; INTRAVENOUS DRUG ADMINISTRATION; LIVER ABSCESS; LIVER METASTASIS; LIVER PARENCHYMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0030463715     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199612000-00008     Document Type: Article

References (23)

1. Berland LL. Slip-ring and conventional dynamic hepatic CT: Contrast material and timing considerations. Radiology 1995;195:1-8.
2. McCarthy S, Moss AA. The use of a flow rate injector for contrast-enhanced computed tomography. Radiology 1984;151:800.
3. Runge VM, Kirsch JE, Woolfolk C, et al. Gadoteridol dose dependence in MR imaging of a liver abscess model. J Magn Reson Imag 1994;4:343-350.
4. Ferrucci JT. Liver tumor imaging: Current concepts. Radiol Clin North Am 1994;32:39-54.
5. Edelman RR, Siegel JB, Singer A, et al. Dynamic MR imaging of the liver with Gd-DTPA: Initial clinical results. AJR Am J Roentgenol 1989;153:1213-1219.
6. Mirowitz SA, Lee JKT, Gutierreze E, et al. Dynamic gadolinium enhanced rapid acquisition spin echo MR imaging of the liver. Radiology 1991;179:371-376.
7. Carr DH, Graif M, Niendorf HP, et al. Gadolinium DTPA in the assessment of liver tumours by magnetic resonance imaging. Clin Radiol 1986;37:347-53.
8. Semelka RC, Brown ED, Ascher SM, et al. Hepatic hemangiomas: A multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology 1994;192:401-406.
9. Pavone P, Patrizio G, Buoni C, et al. Comparison of Gd-BOPTA with Gd-DTPA in MR imaging of rat liver. Radiology 1990; 176:61-64.
10. Cavagna F, Dapra M, Maggioni F, de Haen C, Felder E. Gd-BOPTA/Dimeg: Experimental disease imaging. Magn Reson Med 1991;22:329-333: discussion: 343-346.
11. Caramia F, Foley MT, Moore J, et al. Use of Gd BOPTA/dimeglumine in peripheral magnetic resonance angiography. Presented at the proceedings of the International Society for Magnetic Resonance in Medicine. Fourth Scientific Meeting; April 1996; New York, NY.
12. Cavagna FM, Marzola P, Dapra M, et al. Binding of gadobenate dimeglumine to proteins extravasated into interstitial space enhances conspicuity of reperfused infarcts. Invest Radiol 1994;29(suppl 2):S50-S53.
13. Schuhmann-Giampieri G. Liver contrast media for magnetic resonance imaging. Interrelations between pharmacokinetics and imaging. Invest Radiol 1993;28:753-761.
14. Dawson P, Blomley M. Gadolinium chelate MR contrast agents. Clin Radiol 1994;49:439-42. Editorial.
15. Low RN, Francis IR, Sigeti JS, Foo TKF. Abdominal MR imaging: Comparison of T2-weighted fast and conventional spin-echo, and contrast-enhanced fast multiplanar spoiled gradient-recalled imaging. Radiology 1993;186:803-811.
16. Nazarian LN, Spencer JA, Mitchell DG. Multiple actinomycotic liver abscesses: MRI appearances with etiology suggested by abdominal radiography. Clin Imaging 1994;18:119-122. Case report.
17. Mendez RJ, Schiebler ML, Cutwater EK, Kressel HY. Hepatic abscesses: MR imaging findings. Radiology 1994;190:431-436.
18. Hayashi T, Honda H, Kaneko K, et al. Hepatocellular carcinoma with pyrexia: Report of a case. Radiat Med 1995;13:133-136.
19. Kreft BP, Tanimoto A, Stark DD, et al. Enhancement of tumor-liver contrast-to-noise ratio with gadobenate dimeglumine in MR imaging of rats. J Magn Reson Imag 1993;3:41-49.
20. Pavone P, Patrizio G, Buoni C, et al. Comparison of Gd-BOPTA with Gd-DTPA in MR imaging of rat liver. Radiology 1990;176:61-64.
21. Rosati G, Pirovano G, Spinazzi A. Interim results of phase II clinical testing of gadobenate dimeglumine. Invest Radiol 1994;29(suppl 2):S183-S185.
22. Vogl TJ, Pegios W, McMahon C. et al. Gadobenate dimeglumine: A new contrast agent for MR imaging: Preliminary evaluation in healthy volunteers. AJR Am J Roentgenol 1992;158:887-892.
23. Hamm B, Staks T, Muhler A, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: Safety, pharmacokinetics, and MR imaging. Radiology 1995;195:785-792.